RxDoctor Payments Data

Cesar Kalombo, NP

Adult Health · Reidsville, NCNPI 1568935039

Payments from drug & device makers

$532in general payments, 2019–2025

Across 27 payments — averaging $19.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$138
  • AstraZeneca$86
  • Mylan Specialty L.p.$68
  • Novo Nordisk$46
  • Merck$41
  • Novartis$34
  • plus $118 from 6 others

What the payments were for

  • Food & beverage$532100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$532 in reported general payments places this provider in the 50th percentile of 614 adult health providers in North Carolina.

See all adult health providers in North Carolina

Medicare billing

Part B allowed, 2024
$21,801
Medicare patients
46
Services billed
256

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin50$62,177
OzempicSemaglutide38$57,637
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$36,917
EliquisApixaban29$34,434
MyrbetriqMirabegron30$26,471
TrulicityDulaglutide22$20,153
LinzessLinaclotide18$18,644
JanuviaSitagliptin Phosphate17$15,461
SymbicortBudesonide/Formoterol Fumarate55$14,021
VascepaIcosapent Ethyl15$9,419
Breztri AerosphereBudesonide/Glycopyr/Formoterol14$9,110
Oxymorphone Hcl ErOxymorphone Hcl13$8,548
Stiolto RespimatTiotropium Br/Olodaterol Hcl15$7,473
Tresiba Flextouch U-100Insulin Degludec13$6,253
Combivent RespimatIpratropium/Albuterol Sulfate13$6,223

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Stiolto Respimat, Combivent Respimat$19$75,87278 claims
Novo NordiskOzempic$46$57,63738 claims
GSKTrelegy Ellipta$25$36,91742 claims
AstraZenecaSymbicort, Breztri Aerosphere$86$23,13069 claims
Lilly USA, LLCTrulicity$138$20,15322 claims
AbbVieLinzess$31$18,64418 claims
MerckJanuvia$41$15,46117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 614 adult health providers in North Carolina.

Other adult health in Reidsville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →